Role Overview
Be part of a high‑impact Semaglutide launch and drive the future of diabetes care. This role offers a unique opportunity to promote a blockbuster GLP‑1 therapy, shape prescriber behaviour, and accelerate market leadership in the Cardio‑Metabolic segment.
Key Responsibilities
Lead Semaglutide launch execution in the assigned territory with aggressive focus on coverage, prescriptions, and market share.
Deliver high‑science product detailing highlighting Semaglutide’s superior efficacy, weight‑loss benefits, and cardiovascular outcomes.
Build strong engagement with diabetologists and cardiologists, positioning yourself as the go‑to expert for Semaglutide.
Drive rapid prescription adoption through focused planning, CME initiatives, and strategic doctor conversion.
Track competitor GLP‑1 activity and provide sharp market insights.
Eligibility & Profile
Age: Below 30 years
Education: B.Sc / B.Pharm
Experience into Cardio / Diabetes is mandatory, freshers can be considered however B.Pharma is mandatory
Prior exposure to Semaglutide GLP‑1 therapies highly preferred
Hunger to win, strong execution skills, and launch‑oriented mindset
Perks
Best‑in‑industry compensation
Opportunity to work on a mega‑brand Semaglutide